John Tagliamonte

Plus aucun poste en cours

59 ans

Health Technology

Health Services

Consumer Services

Profil

John A. Tagliamonte formerly worked at Mellitus LLC, as Chief Executive Officer & Director from 2020 to 2024, Johnson & Johnson, as Director-Strategy & Business Development, Bio-Rad Laboratories, Inc., as Manager-Global Product Lines, ImmunoGen, Inc., as Vice President-Business Development from 2004 to 2005, Anchor Therapeutics, Inc., as Vice President-Business Development, HemoShear Therapeutics, Inc., as Chief Business Officer, Dana-Farber Cancer Institute, Inc., as Scientist-Cell & Molecular Biology, Laureate Biopharmaceutical Services, Inc., as Head-Business Development, Selventa, Inc., as Senior Vice President-Corporate Development, and Oxyrane UK Ltd., as Chief Business Officer.
Mr. Tagliamonte received his Masters Business Admin degree from Boston College and undergraduate degree from Tufts University.

Anciens postes connus de John Tagliamonte

Sociétés	Poste	Fin
Mellitus LLC Mellitus LLC BiotechnologyHealth Technology Develops in vitro diagnostic tests for the measurement of Glycated CD59	Directeur Général	01/06/2024
IMMUNOGEN, INC.	Corporate Officer/Principal	01/01/2005
JOHNSON & JOHNSON	Corporate Officer/Principal	-
Oxyrane UK Ltd. Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Develops novel enzyme replacement therapies	Corporate Officer/Principal	-
Dana-Farber Cancer Institute, Inc. Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients	Corporate Officer/Principal	-

Voir l'expérience en détail de John Tagliamonte

Formation de John Tagliamonte

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de John Tagliamonte

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	12
Bio-Rad Laboratories, Inc. Bio-Rad Laboratories, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes life science research products & clinical diagnostics	Health Technology
ImmunoGen, Inc. ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics	Health Technology
Johnson & Johnson Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products	Health Technology
Anchor Therapeutics, Inc. Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Designs and develops peptide modulators of G protein-coupled receptors	Health Technology
HemoShear Therapeutics, Inc. HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services Creates human relevant systems that replicate the biology of organ systems and diseases	Health Services
Mellitus LLC Mellitus LLC BiotechnologyHealth Technology Develops in vitro diagnostic tests for the measurement of Glycated CD59	Health Technology
Dana-Farber Cancer Institute, Inc. Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients	Health Services
Laureate Biopharmaceutical Services, Inc. Laureate Biopharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical development and protein production services	Health Technology
Boston College Boston College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tufts University Tufts University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Selventa, Inc. Selventa, Inc. Miscellaneous Commercial ServicesCommercial Services Develops new approaches for the understanding and treatment of diseases	Commercial Services
Oxyrane UK Ltd. Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Develops novel enzyme replacement therapies	Health Technology